Hospitals May Be Sitting on Millions in Untapped Medication Cost Savings
Hospitals May Be Sitting on Millions in Untapped Medication Cost Savings
Intelliguard’s new interactive ROI tool helps U.S. and Canadian health systems quantify potential five-year savings across medication inventory, labor, waste, charge capture and supply-chain management
Intelliguard, a leader in RFID-enabled medication inventory management, today announced the launch of its new Interactive ROI Calculator, designed to help hospital and health system leaders quickly estimate the potential five-year financial impact of improving how medications are managed across their organizations.
Intelliguard modeled multiple hospitals and health systems reflecting real-world operating profiles. To illustrate these savings, the company applied its methodology to a representative six-hospital regional health system. Grounded in published industry research and Intelliguard’s operational benchmarks, including customer outcomes like a 90% reduction in tray refill times and cutting monthly medication waste from 8.5% to under 3% of encoded medicines, the analysis identified a potential $51 million five-year financial opportunity, including:
- $20M in drug inventory management
- $13M in 340B revenue capture
- $12M in charge capture
- $6M in waste reduction
An overlooked financial opportunity
Medication inventory is one of the largest and most complex areas of hospital operations, yet many health systems lack a simple way to quantify the financial impact of inventory inefficiencies.
Excess inventory ties up working capital. Medications expire before they can be used. Pharmacy teams spend valuable time on manual inventory and replenishment activities. Incomplete documentation can contribute to missed charge capture and, for eligible U.S. hospitals, unrealized 340B opportunities.
The Healthcare Financial Management Association has reported that hospitals can lose as much as 1% of net revenue to charge-capture leakage system-wide. Research published in JAMA Health Forum also found that while the share of 340B-eligible prescriptions captured by 340B pharmacies increased substantially between 2013 and 2020, covered entities were still capturing only about half of the 340B revenue for which they were eligible.
From operational inefficiencies to financial impact
“Hospital leaders are being asked to find meaningful efficiencies while continuing to manage increasingly complex medication environments,” said Jeff Harper, Head of Product at Intelliguard. “The challenge is knowing where the biggest opportunities are and whether they are significant enough to act on. This tool gives pharmacy, supply chain and finance leaders a quick way to use their own data to understand where better medication inventory management could create measurable value.”
Hospital and health system leaders can model their potential five-year opportunity in minutes at intelliguardhealth.com/roi-calculator/.
The five-year savings figures cited above reflect an illustrative example built to mirror the scale of real-world hospital operating profiles and generated using Intelliguard’s Cost Savings Calculator methodology. Results are not an audited outcome for any specific hospital and will vary based on each health system’s inputs, workflows, medication spend, current level of automation and other circumstances.
About Intelliguard
Intelliguard is a healthcare technology company focused on improving how hospitals and health systems manage high-value, high-risk medications and supplies. With more than 25 years of experience in RFID-based automation, Intelliguard is a trusted partner known for delivering accurate, reliable medication inventory management. Its Mira Ecosystem™ is healthcare’s only connected RFID-based medication inventory platform, unifying real-time visibility, analytics, and open, interoperable infrastructure into a single system. It supports medication inventory management from intake through storage, movement, and provider access, enabling health systems to manage critical inventory with precision, control, and confidence. For more information, visit intelliguardhealth.com.
Kelly Biele
kbiele@cglife.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20260921036025/en/
The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
5 Stocks to Buy Trading at Big Discounts
2 Undervalued Stocks to Buy With Long-Term Growth Ahead
The Market May Be Too Pessimistic About This 4-Star Dividend Stock
4 Stocks to Buy for the Long-Term While They’re Still Undervalued